Washington D.C., Jan 24, 2005 / 22:00 pm
The Federal Drug Administration has delayed its decision about whether to make the morning-after pill available over the counter. The morning-after pill is also known as Plan B.
The FDA had aimed to have a decision by Jan. 21, but Barr Pharmaceuticals said in a statement Friday that the FDA told the company it was unable to complete its review by then.
According the statement, the FDA said, "it is committed to completing its review of the application in the near future."
The FDA had rejected the over-the-counter proposal last year, stating that there was a lack of information about the drug’s effect on teenagers.
Barr submitted another application for the drug about six months ago, proposing that Plan B be made available without prescription to women, aged 16 and over. A prescription would be required for anyone under 16.
Hours after the company announced the delay, the Center for Reproductive Rights filed suit against the FDA in a New York federal court for failing to approve Plan B for over-the-counter access.
Subscribe to our daily newsletter
At Catholic News Agency, our team is committed to reporting the truth with courage, integrity, and fidelity to our faith. We provide news about the Church and the world, as seen through the teachings of the Catholic Church. When you subscribe to the CNA UPDATE, we'll send you a daily email with links to the news you need and, occasionally, breaking news.
As part of this free service you may receive occasional offers from us at EWTN News and EWTN. We won't rent or sell your information, and you can unsubscribe at any time.
Click hereOur mission is the truth. Join us!
Your monthly donation will help our team continue reporting the truth, with fairness, integrity, and fidelity to Jesus Christ and his Church.
Donate to CNA